Brief: Bubs Australia Says Us-Based Infant Formula Clinical Trial

Bubs Australia

07/09/2023 02:36

Sept 7 (Reuters) - Bubs Australia  BUB.AX :
    * BUBS ANNOUNCES US-BASED INFANT FORMULA CLINICAL TRIAL
    * PLANS TO SUBMIT RESULTS FROM GMS TO FDA BY SEPTEMBER 2024
WITH A
FULL INFANT FORMULA SUBMISSION BY OCTOBER 2024
    * BUBS IS ACTIVELY TAKING STEPS TO TRANSITION FROM TEMPORARY
'ENFORCEMENT DISCRETION' TO A PERMANENT MARKET POSITION
    * STUDY DESIGNED TO EVALUATE GROWTH, TOLERANCE, AND SAFETY
OF NEW
INFANT FORMULAS

Source text for Eikon:  ID:nASXb0b3bf 
Further company coverage:  BUB.AX 

 ((Reuters.Briefs@thomsonreuters.com;))